Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25608| Title: | Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing. | Austin Authors: | Barthel, Henryk;Seibyl, John;Lammertsma, Adriaan A;Villemagne, Victor L ;Sabri, Osama | Affiliation: | Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany Medicine (University of Melbourne) Institute for Neurodegenerative Disorders, New Haven, Connecticut Molecular Imaging and Therapy Department of Radiology and Nuclear Medicine, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands |
Issue Date: | Aug-2020 | Date: | 2020-05-15 | Publication information: | Journal of Nuclear Medicine 2020; 61(8): 1105-1106 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25608 | DOI: | 10.2967/jnumed.119.228346 | Journal: | Journal of Nuclear Medicine | PubMed URL: | 32414946 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.